3 Comments 3 Comments
The new Real Health product introduces new $500,000 limits on surgical and non-surgical treatments, including new generation, non-Pharmac treatments for cancer, such as the innovative immunotherapy treatments, that are otherwise unaffordable for the average New Zealander.
AIA chief executive Natalie Cameron says: “Our new Real Health policy directly addresses the affordability issues for these new treatments, but we’re also moving to address the general affordability of insurance cover for the average New Zealander by introducing a generous discount regime on premiums.”
AIA customers who purchase the Real Life policy together with other insurance policies receive an escalating discount per extra policy.
“The more policies that are bundled up, the greater the discount that is available,” Cameron says.
The two initiatives, taken together, will increase the number of New Zealanders gaining access to the latest life-saving drugs and treatments, she added.
“These new drugs and treatments are coming to market quickly and although there is uncertainty around when and how much they will cost, we can be sure that costs will continue to rise,” comments Cameron. “The insurance industry is about effectively managing risk and we are introducing this new product now in the expectation that New Zealanders will need that level of support in the near future.”
As the second largest life insurer in the world, AIA is serious about investing in the New Zealand insurance industry, Cameron says. “The AIA group has a market capitalisation of $116.34b, and that gives us the economies of scale to provide New Zealand families with an affordable choice,” Cameron says.
“We aim to be a serious industry player offering innovative products, with real benefits, that are more relevant to people’s lives than our competitors’ offering.”
| « Life is good for retirees, report shows | Online prep for new advice clients » |
Special Offers
Sign In to add your comment
© Copyright 1997-2025 Tarawera Publishing Ltd. All Rights Reserved
We have an affordability issue in NZ where about 70% of medical insurance would not exist but for employer paid cover
Private Medical insurance should be for elective items, and basically to avoid the waiting list
It should not be for medical people to divert you to private care for life threatening issues, where there is no waiting list
If the industry wants to get back to 50% plus insurance, get away from this. In the main it is window dressing anyway, but it creates an opportunity for the specialists to order the new Bugatti for Wife